As world leaders descended on the COP26 climate change conference in Glasgow this week, several pharma companies promoted their own ESG pledges.

First, Moderna on Monday outlined a commitment to achieve net-zero carbon emissions globally by 2030. The announcement touted a plan to use renewable or offset energy in all U.S. facilities starting this year and to implement sustainable construction for new plants in Africa and Canada. CEO Stéphane Bancel said in the press release that…

Three pharmas published environmental, social and governance commitments this week.

First, BD released its 2021 Together We Advance strategy, promising to achieve carbon neutrality across direct operations by 2040, to work with supply chain partners on labor and environmental practices, and to improve ethnic and gender diversity at its management and executive levels by 1% year over year, among other measures.

Next up, GSK’s HIV subsidiary ViiV released a report conducted by…


Moderna announced last week its launch of a foundation to promote “public health, healthcare and educational opportunities,” with an initial endowment of $50 million. The Moderna Charitable Foundation is the first public social good commitment for the maker of the blockbuster Covid-19 vaccine.

Meanwhile, Novartis last week announced a 10-year collaboration with multiple U.S.-based historically Black colleges and universities (HBCUs) and HCBU medical schools to co-create programs that…